International Fetal Transplantation
and Immunology Society
2023
The goals and objectives of the Society are:
To promote basic and translational research leading to the development of fetal therapies
To raise public and scientific awareness of the need for development of fetal treatments
To develop and maintain an international registry of treated patients and their outcomes to facilitate reporting and sharing of results. This database will not be publicly accessible and data should be anonymized.
To promote the establishment of mutually beneficial collaborations among its members
Our mission
To accelerate clinical applications of stem cell transplantation and gene therapy approaches, to treat fetuses with congenital disorders.
Our vision
Eliminate disease before it starts
Current President
Tippi Mackenzie, MD
University of California, San Francisco
Division of Pediatric Surgery and the Fetal Treatment Center
President Elect
Anna David, PhD
UCL Institute for Women's Health
Past President(s)
Christopher D. Porada PhD
Wake Forest Institute for Regenerative Medicine
Secretary
Citra Mattar, MD
National University of Singapore
Treasurer
William H. Peranteau, MD
Children's Institute for Surgical Science at the Children's Hospital of Philadelphia
Board of Directors
Graça Almeida-Porada, MD, PhD
Wake Forest Institute for Regenerative Medicine
Karin Blakemore
Prenatal Genetics, Prenatal Diagnostic Center
John Hopkins Medicine
Paolo De Coppi, MD, PhD
UCL Institute of Child Health in London
Alan W. Flake, MD, FACS, FAAP
Children's Institute for Surgical Science at the Children's Hospital of Philadelphia
Cecilia Götherström, PhD
Karolinska University Hospital
Tippi Mackenzie, MD
University of California San Francisco
Magnus Westgren, MD, PhD
Karolinska University Hospital
Founding Presidents
Tippi Mackenzie, MD
University of California, San Francisco
Division of Pediatric Surgery and the Fetal Treatment Center
Graça Almeida-Porada, MD, PhD
Wake Forest Institute for Regenerative Medicine
Fetal Research and Therapy Center